Deloitte has filed a motion to dismiss a $172 million lawsuit filed by Zimmer Biomet, according to a Nov. 10 report from MassDevice.
Zimmer Biomet filed the lawsuit in September, accusing Deloitte of mismanaging a resource planning software system. The lawsuit seeks to recoup the $94 million in fees paid to Deloitte, $15 million invoiced as Deloitte attempted to fix the errors and $72 million to cover Zimmer’s additional post-go-live costs.
Deloitte submitted more than 10 documents to the Supreme Court of the State of New York in Manhattan on Nov. 7, including a memorandum of law and 10 exhibits.
According to the court documents, Deloitte is claiming that Zimmer Biomet did not properly notify the company of the breach of contract, and that Zimmer’s lawsuit should not hold up because private contracts between two parties is not considered “consumer-oriented” conduct.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
